Average Co-Inventor Count = 9.32
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
2. Amgen Inc. (3 from 1,974 patents)
3. Relay Therapeutics, Inc. (2 from 12 patents)
4. D.e. Shaw Research, LLC (1 from 27 patents)
15 patents:
1. 12331056 - SHP2 phosphatase inhibitors and methods of use thereof
2. 12215116 - Arginase inhibitors and methods of use
3. 12084447 - SHP2 phosphatase inhibitors and methods of use thereof
4. 12030872 - N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
5. 11174248 - Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
6. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
7. 10975084 - KDM5 inhibitors
8. 10689369 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
9. 10584121 - Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
10. 10344000 - Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
11. 10287272 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
12. 10221142 - Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
13. 9663508 - Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
14. 9505749 - Quinazolinone compounds and derivatives thereof
15. 9340549 - Oxazolidinone compounds and derivatives thereof